Dual GIP + GLP-1 agonist. SURMOUNT-1 trial: 22.5% average body weight loss at 72 weeks. Over half of max-dose patients lost 20%+.
Tap dots for details. Scroll horizontally to see full timeline.
“By week 3 I had lost 8 lbs. Wasn't even trying to diet.”
“Something clicked. Food chatter just... stopped.”
“Week 12 down 23 lbs. My knees don't hurt anymore.”
“Faster, stronger, less nausea than Ozempic.”
“Results that used to require bariatric surgery.”
2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg progressive escalation